{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-22-024265","form_type":"8-K","ticker":"ECOR","cik":"0001560258","company_name":"electroCore, Inc.","filed_at":"2022-05-05T23:59:59+00:00","discovered_at":"2026-05-14T18:04:01.196486+00:00","generated_at":"2026-06-25T23:39:23.059684+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"electroCore Q1 revenue $1.9M, up 58% YoY; net loss $5.6M","bullets":["Net sales $1.9M, up 58% from Q1 2021 and 27% sequentially.","GAAP net loss $5.6M; adjusted EBITDA net loss $4.6M.","Cash and equivalents $29.9M at March 31, 2022; operating cash used $4.8M.","Q2 2022 guidance: revenue at least $1.9M; cash used ~$3.5M.","FDA Breakthrough Device for PTSD; exclusive Japan license with Teijin."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-22-024265","json":"https://secwatch.observer/filing/0001213900-22-024265.json","markdown":"https://secwatch.observer/filing/0001213900-22-024265.md","text":"https://secwatch.observer/filing/0001213900-22-024265.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1560258/000121390022024265/0001213900-22-024265-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1560258/000121390022024265/ecor-20220505.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T23:39:23.059684+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}